F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
36.44
-0.22 (-0.59%)
May 19, 2026, 4:00 PM EDT - Market closed
LFSC Holdings Information
LFSC is an equity ETF with a total of 42 individual holdings. The top holdings are Cogent Biosciences stock at 7.55%, Travere Therapeutics at 7.35%, LivaNova at 7.08%, Spyre Therapeutics at 6.77%, and Mirum Pharmaceuticals at 5.54%.
Total Holdings
42
Top 10 Percentage
53.87%
Asset Class
Equity
ETF Category
Health
Assets
97.70M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | COGT | Cogent Biosciences, Inc. | 7.55% |
| 2 | TVTX | Travere Therapeutics, Inc. | 7.35% |
| 3 | LIVN | LivaNova PLC | 7.08% |
| 4 | SYRE | Spyre Therapeutics, Inc. | 6.77% |
| 5 | MIRM | Mirum Pharmaceuticals, Inc. | 5.54% |
| 6 | UTHR | United Therapeutics Corporation | 4.41% |
| 7 | GH | Guardant Health, Inc. | 4.31% |
| 8 | NKTR | Nektar Therapeutics | 3.69% |
| 9 | MANE | Veradermics, Incorporated | 3.68% |
| 10 | BBIO | BridgeBio Pharma, Inc. | 3.49% |
| 11 | TRVI | Trevi Therapeutics, Inc. | 3.41% |
| 12 | SVRA | Savara Inc. | 3.35% |
| 13 | DNTH | Dianthus Therapeutics, Inc. | 2.91% |
| 14 | AXSM | Axsome Therapeutics, Inc. | 2.89% |
| 15 | RBIL | F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF | 2.85% |
| 16 | CYTK | Cytokinetics, Incorporated | 2.27% |
| 17 | VRDN | Viridian Therapeutics, Inc. | 2.27% |
| 18 | CRVS | Corvus Pharmaceuticals, Inc. | 2.20% |
| 19 | TMDX | TransMedics Group, Inc. | 2.13% |
| 20 | PVLA | Palvella Therapeutics, Inc. | 2.00% |
| 21 | ICUI | ICU Medical, Inc. | 1.95% |
| 22 | CORT | Corcept Therapeutics Incorporated | 1.92% |
| 23 | ITGR | Integer Holdings Corporation | 1.46% |
| 24 | BLLN | BillionToOne, Inc. | 1.45% |
| 25 | CBLL | CeriBell, Inc. | 1.42% |
As of May 14, 2026